Enhanced drug delivery in transdermal systems
First Claim
1. A method of adjusting the blood level profile or permeation of a drug from a transdermal drug delivery composition, comprising:
- (a) selecting a parent drug and a corresponding prodrug, wherein the parent drug is a steroid and the prodrug is a corresponding steroid derivative that provides a source of therapeutically active steroid;
(b) combining the parent drug and prodrug in a carrier that includes at least one pressure-sensitive adhesive, wherein the steroid and corresponding steroid derivative are present in a wt/wt ratio of from 10;
1 to 1;
10 steroid;
corresponding steroid derivative;
(c) measuring the permeation and/or blood level profile of the drug;
(d) adjusting at least one of;
(i) the selection of the corresponding prodrug and (ii) the relative concentration of the parent drug and prodrug,wherein the parent drug is a steroid comprising a steroid ring with a free hydroxy group at position 3, 11 or 17 and the prodrug is a corresponding steroid derivative where the free hydroxy group at the 3, 11 or 17 position has been reacted with an alcohol moiety.
0 Assignments
0 Petitions
Accused Products
Abstract
A composition for transdermal administration resulting from an admixture includes: a therapeutically effective amount of a drug that includes a parent drug and a prodrug; and and a pharmaceutically acceptable carrier, wherein the parent drug and prodrug are individually present in an amount sufficient for a pharmacological effect. In a preferred embodiment, the admixture includes: a therapeutically effective amount of a pharmaceutically active agent that includes a corresponding steroid and a steroid derivative; and a carrier for the pharmaceutically active agent. The steroid and the corresponding steroid derivative are present in a weight ratio of 10:1 to 1:10 steroid: corresponding steroid derivative. In a preferred embodiment ratio is 6:1 to 1:6. In a preferred embodiment, the corresponding steroid derivative is a steroid ester. In another preferred embodiment, the carrier is a polymer that includes a pressure-sensitive adhesive. In another preferred embodiment, the parent drug is an ACE inhibitor such as ramipril and the prodrug is an ACE inhibitor prodrug such as ramipril ethyl and/or methyl ester.
-
Citations
13 Claims
-
1. A method of adjusting the blood level profile or permeation of a drug from a transdermal drug delivery composition, comprising:
-
(a) selecting a parent drug and a corresponding prodrug, wherein the parent drug is a steroid and the prodrug is a corresponding steroid derivative that provides a source of therapeutically active steroid; (b) combining the parent drug and prodrug in a carrier that includes at least one pressure-sensitive adhesive, wherein the steroid and corresponding steroid derivative are present in a wt/wt ratio of from 10;
1 to 1;
10 steroid;
corresponding steroid derivative;(c) measuring the permeation and/or blood level profile of the drug; (d) adjusting at least one of;
(i) the selection of the corresponding prodrug and (ii) the relative concentration of the parent drug and prodrug,wherein the parent drug is a steroid comprising a steroid ring with a free hydroxy group at position 3, 11 or 17 and the prodrug is a corresponding steroid derivative where the free hydroxy group at the 3, 11 or 17 position has been reacted with an alcohol moiety. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
Specification